Potential Utility of Endoscopic Ultrasonography Under Sedation with Remimazolam Plus Pethidine Hydrochloride
Open Access
- 19 August 2026
- journal article
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
Abstract
Endoscopic ultrasonography (EUS) requires sedation due to its strong discomfort. In recent years, the effectiveness of sedation using remimazolam as well as pethidine hydrochloride has been reported. However, the utility of sedation with remimazolam plus pethidine hydrochloride for EUS has not been determined. A total of 325 consecutive outpatient EUS cases performed between January and August 2025 were retrospectively reviewed. Statistical comparisons were performed using Fisher's exact test or the Mann–Whitney U test. Analyses were conducted using BellCurve for Excel, Version 4.08 (Social Survey Research Information Co., Ltd., Tokyo, Japan). A p-value <0.05 was considered statistically significant. Men accounted for 52.9% of the cohort, the median age was 71 years, and 67.1% had American Society of Anesthesiologists physical status of I. Pethidine hydrochloride (35 mg) was administered in all cases. The median initial dose of remimazolam was 2 mg (1–3 mg), and the median dose required until scope insertion was 3 mg (1–7 mg). The median EUS procedure time was 12 minutes. The median total remimazolam dose until EUS completion was 4 mg (1–15 mg). The procedure completion rate without rescue sedation was 96.6%. The median time from EUS procedure completion to patient exit from the endoscopy room was 44 minutes. There were 25 cases (7.7%) of sedation-related adverse events (AEs), with cardiorespiratory AEs occurring in 3.7% of cases. Outpatient EUS under sedation with remimazolam and pethidine hydrochloride achieved a high procedure completion rate and few cardiorespiratory AEs.Keywords
This publication has 24 references indexed in Scilit:
- Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single‐Center Retrospective Cohort StudyDEN Open, 2026
- Comparison of sedation with pentazocine or pethidine hydrochloride for endoscopic ultrasonography in outpatients: A single‐center retrospective studyDEN Open, 2024
- Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysisBritish Journal of Anaesthesia, 2024
- Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsisInternational Journal of Clinical Oncology, 2023
- Efficacy and Safety of the Remimazolam-Alfentanil Combination for Sedation During Gastroscopy: A Randomized, Double-blind, Single-center Controlled TrialClinical Therapeutics, 2022
- Remimazolam anaphylaxis during anesthesia inductionJournal of Anesthesia, 2021
- Endoscopic ultrasonography for pancreatic solid lesionsJournal of Medical Ultrasonics, 2019
- Guidelines for sedation and anesthesia in GI endoscopyGastrointestinal Endoscopy, 2018
- Adverse events associated with ERCPGastrointestinal Endoscopy, 2017
- The post-anesthesia recovery score revisitedJournal of Clinical Anesthesia, 1995